Production of 1,5-anhydroglucitol from 1,5-anhydrofructose in erythroleukemia cells

被引:46
|
作者
Suzuki, M
Kametani, S
Uchida, K
Akanuma, H
机构
[1] UNIV TOKYO,GRAD SCH ARTS & SCI,DEPT LIFE SCI CHEM,MEGURO KU,TOKYO 153,JAPAN
[2] SAITAMA UNIV,FAC ENGN,DEPT FUNCT MAT SCI,URAWA,SAITAMA,JAPAN
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1996年 / 240卷 / 01期
关键词
1,5-anhydroglucitol; 1,5-anhydrofructose; glycogen; glycogenolysis;
D O I
10.1111/j.1432-1033.1996.0023h.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pyranoid polyol 1,5-anhydroglucitol (1,5AnGlc-ol) occurs in a wide variety of organisms. Tn humans, it is present as one of the major monosaccharide components in body fluids and serves as an indicator for glycemic control in diabetic care. However, its metabolic origin and fate have been poorly understood. Here we demonstrate that 1,5AnGlc-ol is produced from glucose in erythroleukemia cells, K-562. We show the occurrence of 1,5-anhydrofructose (1,5AnFru), a derivative of 1,5AnGlc-ol oxidized at the C2 position, in K-562 cells. In addition, several pieces of evidence indicated that 1,5AnFru, rather than glucose, was the immediate precursor in 1,5AnGlc-ol production in erythroleukemia cells: exogenous 1,5AnFru was readily taken up into the cells and reduced to 1,5AnGlc-ol, but the reverse reaction, oxidation of 1,5AnGlc-ol to 1,5AnFru, was scarcely observed. The apparent K-m of the overall cellular reduction for 1,5AnFru was estimated as 70 mg/l. This reduction was markedly inhibited by glucose in the culture medium but not by 1,5AnGlc-ol or glucitol. Since 1,5AnFru arises from alpha-1,4-glucans through lyase reactions in fungi and algae, we suggest the possibilities that glycogen is the precursor of 1,5AnFru and, therefore, 1,5AnGlc-ol originates from glycogen in mammals.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [1] Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway
    Kametani, S.
    Shiga, Y.
    Akanuma, H.
    European Journal of Biochemistry, 242 (03):
  • [2] Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway
    Kametani, S
    Shiga, Y
    Akanuma, H
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 242 (03): : 832 - 838
  • [3] The third glycogenolytic pathway which produces 1,5-anhydrofructose and 1,5-anhydroglucitol
    Akanuma, H
    Kametani, S
    Shiga, Y
    Sakuma, M
    Kadokura, T
    Suzuki, M
    FASEB JOURNAL, 1997, 11 (09): : A984 - A984
  • [4] The metabolism and transport of 1,5-anhydroglucitol in cells
    Ying, Lingwen
    Ma, Xiaojing
    Yin, Jun
    Wang, Yufei
    He, Xingxing
    Peng, Jiahui
    Bao, Yuqian
    Zhou, Jian
    Jia, Weiping
    ACTA DIABETOLOGICA, 2018, 55 (03) : 279 - 286
  • [5] The metabolism and transport of 1,5-anhydroglucitol in cells
    Lingwen Ying
    Xiaojing Ma
    Jun Yin
    Yufei Wang
    Xingxing He
    Jiahui Peng
    Yuqian Bao
    Jian Zhou
    Weiping Jia
    Acta Diabetologica, 2018, 55 : 279 - 286
  • [6] 1,5-Anhydroglucitol in diabetes mellitus
    Won Jun Kim
    Cheol-Young Park
    Endocrine, 2013, 43 : 33 - 40
  • [7] 1,5-Anhydroglucitol in diabetes mellitus
    Kim, Won Jun
    Park, Cheol-Young
    ENDOCRINE, 2013, 43 (01) : 33 - 40
  • [8] Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
    Tanaka, Kenji
    Sakasai-Sakai, Akiko
    Motomiya, Yasuki
    Yoneda, Tatsuo
    Takeuchi, Masayoshi
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [9] Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
    Kenji Tanaka
    Akiko Sakasai-Sakai
    Yasuki Motomiya
    Tatsuo Yoneda
    Masayoshi Takeuchi
    Diabetology & Metabolic Syndrome, 13
  • [10] 1,5-anhydroglucitol stimulates insulin secretion in insulinoma cells
    Inoue, Tae
    Ichiyanagi, Kaoru
    Yamanouchi, Toshikazu
    DIABETES, 2006, 55 : A590 - A590